昊帆生物：关于开立和注销部分募集资金现金管理专用结算账户的公告

Group 1 - The core point of the article is that Haofan Bio has announced the establishment of a dedicated settlement account for cash management of raised funds by its wholly-owned subsidiary, Huai'an Haofan Biopharmaceutical Co., Ltd [1] - The company has completed the cancellation procedures for certain dedicated settlement accounts for cash management of raised funds, as the related financial products have all matured and been redeemed, with no further usage plans [1]